Europe Ocular Drug Delivery Market Trends and Analysis by 2028
Historic Data: 2019-2020 | Base Year: 2021 | Forecast Period: 2022-2028Europe Ocular Drug Delivery Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (Implantable Ocular Drug Delivery Systems, Particulate Drug Delivery Systems, Nano-Particle Drug Delivery System, and Others), Formulation Type (Liposomes and Nanoparticles, Solution, Emulsion, Suspension, and Ointment), Disease Type (Glaucoma, Diabetic Retinopathy, Dry Eye Syndrome, Macular Degeneration, Cataract, Diabetic Macular Edema, and Others), and End User (Hospitals, Ophthalmic Clinics, and Ambulatory Surgical Centers)
- Report Date : Nov 2021
- Report Code : TIPRE00025762
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 152
The ocular drug delivery market in Europe is expected to grow to US$ 7,921.15 million by 2028 from US$ 4,967.64 million in 2021. The market is estimated to grow at a CAGR of 6.9% from 2021 to 2028.
The incidence of eye diseases has increased significantly. In recent years, various measures and efforts have been taken to create awareness and educate people regarding eye diseases, facilitating patients access to suitable medications and treatments for such conditions. Sightsavers—an international non-governmental organization—works in developing countries to treat and prevent eye diseases. A large population of India resides in rural areas, which has limited or no awareness about eye ailments. With its Rural Eye Health Programme, Sightsavers aims to create awareness, provide high-quality eye health services, and eradicate avoidable blindness in the rural population. Thus, the growing eye health awareness programs are likely to create growth opportunities for the market.
The European region has been massively hit by the COVID-19 spread, with most countries being in lockdown. Routine healthcare services were cancelled, and patients were recommended to avoid hospital visits to minimize the risk of COVID-19 transmission, leading to significant disruption to the provision of healthcare service and patient care. Ophthalmology represents one of the busiest and heavily outpatient-oriented specialties, with around 7.5 million outpatient appointments and over 500,000 surgical procedures being conducted every year in the United Kingdom. The lockdown has resulted in the cancellation of thousands of ophthalmic visits and surgeries; this has potentially led to permanent and significant harm to patient’s vision. Additionally, as per the recent survey – ‘Psychosocial impact of COVID-19 pandemic lockdown on people living with eye diseases in the UK’ which was conducted among the public with eye diseases, highlighted a significant negative psychosocial impact of lockdown on patients with visual impairment, with approximately 50% of the patients express fear of sight loss due to delayed review or treatment.
With the new features and technologies, companies can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the ocular drug delivery market. The Europe ocular drug delivery market is expected to grow at a good CAGR during the forecast period.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
Europe Ocular Drug Delivery Market Segmentation
Europe Ocular Drug Delivery Market – By Technology
- Implantable Ocular Drug Delivery Systems
- Particulate Drug Delivery Systems
- Nano-Particle Drug Delivery System
- Others
Europe Ocular Drug Delivery Market – By Formulation Type
- Solution
- Ointment
- Suspension
- Emulsion
- Liposomes and Nanoparticles
Europe Ocular Drug Delivery Market – By Disease type
- Cataract
- Dry Eye Syndrome
- Macular Degeneration
- Glaucoma
- Diabetic Retinopathy
- Diabetic Macular Edema
- Others
Europe Ocular Drug Delivery Market – By End User
- Hospitals
- Ophthalmic Clinics
- Ambulatory Surgical Centers
Europe Ocular Drug Delivery Market – By Country
- Germany
- France
- United Kingdom
- Italy
- Spain
- Rest of Europe
Europe Ocular Drug Delivery Market – Companies Mentioned
- AbbVie Inc.
- Bausch Health Companies Inc.
- Novartis AG
- Clearside Biomedical, Inc
- Alimera Sciences, Inc.
- GRAYBUG VISION, INC
Europe Ocular Drug Delivery Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 4,967.64 Million |
| Market Size by 2028 | US$ 7,921.15 Million |
| Global CAGR (2021 - 2028) | 6.9% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Technology
|
| Regions and Countries Covered | Europe
|
| Market leaders and key company profiles |
Market Research & Consulting
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.
We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, Market Research
The research report delivered details on drivers and restraints, trends, and opportunities, along with strategic activities in the market. Previously, we were struggling to get reliable information.
Manager Medical Devices ManufacturingReason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.
- AbbVie Inc.
- Bausch Health Companies Inc.
- Novartis AG
- Clearside Biomedical, Inc
- Alimera Sciences, Inc.
- GRAYBUG VISION, INC
Get Free Sample For